Formulating delayed release rasagiline

A stable oral dosage form comprising a core having rasagiline base form resulting from a production process and at least one pharmaceutically acceptable excipient; resistant coating and pharmaceutically acceptable acid, the production process comprising a) preparing the core by admixing rasagiline base, citric acid and a pharmaceutically acceptable excipient; b) coating the core with a resistant coating pharmaceutically acceptable acid.